Global Surgical Instruments Market

1 INTRODUCTION OF GLOBAL SURGICAL INSTRUMENTSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL SURGICAL INSTRUMENTSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL SURGICAL INSTRUMENTS MARKET, BY APPLICATION:
5.1 Overview
5.2 Soft Tissue Surgery
5.3 Sterilization Surgery
5.4 Gynecological and Urological Surgery
5.5 Dental Surgery
5.6 Orthopedic Surgery
5.7 Ophthalmic Surgery
5.8 Other Surgeries

6 GLOBAL SURGICAL INSTRUMENTS MARKET, BY TYPE OF ANIMAL:
6.1 Overview
6.2 Small Animals
6.2.1 Canines
6.2.2 Felines
6.2.3 Other Small Animals
6.3 Large Animals
6.3.1 Equines
6.3.2 Other Large Animals

7 GLOBAL SURGICAL INSTRUMENTS MARKET, BY PRODUCT:
7.1 Overview
7.2 Sutures, Staplers, and Accessories
7.3 Handheld Devices
7.3.1 Forceps
7.3.2 Scalpels
7.3.3 Surgical Scissors
7.3.4 Hooks & Retractors
7.3.5 Trocars & Cannulas
7.4 Electrosurgery Instruments
7.5 Other Surgical Instruments

8 GLOBAL SURGICAL INSTRUMENTSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL SURGICAL INSTRUMENTSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 B. Braun Vet Care GmbH
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Medtronic PLC.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Ethicon Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 JørgenKruuse A/S
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Jorgensen Laboratories
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Neogen Corporation
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Smiths Group PLC.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 DRE Veterinary
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Integra Lifesciences Holdings Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Steris Corporation
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

10.11 Germed USA, Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Development

10.12 Surgical Holdings
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook

10.13 Sklar Surgical Instruments
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook

10.14 IM3 Inc.
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook

10.15 Antibe Therapeutics Inc.
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook

11 Appendix
11.1 Related Reports